Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Capital Markets Day

13 Sep 2018 07:00

RNS Number : 6185A
Mercia Technologies PLC
13 September 2018
 

 

RNS

13 September 2018

 

Mercia Technologies PLC

("Mercia" or the "Group") 

 

Notice of Capital Markets Day

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, will host an event for institutional investors, analysts and private investors on Thursday 18 October 2018 at The Brewery, 52 Chiswell St, London EC1Y 4SD starting at 13:00hrs BST.

 

The event will provide guests with an opportunity to interact with a number of the Group's portfolio of Emerging Stars, as well as management teams from companies currently being nurtured via its third-party funds, which provide the Group with its pipeline of future Emerging Stars. The event will include presentations given by Mercia's Executive Directors and five direct investment portfolio companies, being:

 

· Impression Technologies, a leading developer of advanced aluminium lightweighting technology

· Intechnica, a rapidly growing business that provides scalable software solutions to manage high and variable website traffic demand

· Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery

· Medherant, a developer of an innovative transdermal drug delivery patch technology

· nDreams, a leading European developer and publisher focused on VR gaming and experiences content

 

Following the presentations, attendees will have an opportunity to meet those companies presenting as well as the management teams from other Emerging Stars, together with a number of third-party fund portfolio companies, to learn more about their exciting technologies and market opportunities.

In addition, the following Emerging Stars will also be exhibiting:

· Aston EyeTech t/a Eyoto, a developer of next generation eye diagnostics technology

· Intelligent Positioning, a developer of innovative real-time search intelligence and search engine optimisation (SEO) analytics solutions for businesses

· Soccer Manager, a developer of online football management games

· VirtTrade, a developer and publisher of digital trading cards

· Warwick Audio Technologies, a specialist developer of a new generation of planar audio transducers

 

Third-party fund portfolio companies will include:

· Carbon Air, a company focused on creating miniature speakers and extra-thin sound insulation using highly porous materials

· CyberOwl, the developer of a scalable early-warning system for network security

· GENBA Digital, a digital logistics platform that bridges the gap between publishers and resellers of video game content

· Locate Technologies, a developer of a targeted regenerative drug and stem cells delivery system

· Smartgate Solutions, a cloud-based solutions provider supporting global regulated customers to meet operational and regulatory requirements

 

Dr Mark Payton, Chief Executive Officer of Mercia Technologies PLC, said: "Mercia continues to scale its operations and the investment portfolios within its funds and now, through the selective backing of Emerging Stars onto its balance sheet, has built meaningful positions in many exciting, high-growth businesses.

 

The Group is a leading provider of Complete Capital in the key regions of the Midlands, the North of England and Scotland and the portfolio companies joining us from both the funds under management and our direct investments on 18 October will demonstrate the positive momentum that the Group is experiencing, which I am confident will deliver future value for shareholders."

 

For further details on the event and to register your interest in attending please telephone 020 7466 5000 or email merciatechnologies@buchanan.uk.com

 

For further information, please contact:

 

Mercia Technologies PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

 

Martin Glanfield, Chief Financial Officer

 

www.merciatech.co.uk

 

 

 

Cenkos Securities plc

+44 (0)20 7397 8900

Stephen Keys (NOMAD and Joint Broker)

 

 

 

Canaccord Genuity Limited

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel (Joint Broker)

 

 

 

Buchanan

+44 (0)20 7466 5000

Bobby Morse, Chris Lane, Stephanie Watson

 

www.buchanan.uk.com

 

 

 

About Mercia Technologies PLC

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

 

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third-party funds (now with circa £400million under management) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £63million directly across its portfolio of 'Emerging Stars'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGUCABUPRGBP
Date   Source Headline
3rd May 20249:44 amRNSTransaction in Own Shares
26th Apr 202410:00 amRNSTransaction in Own Shares
25th Apr 20249:29 amRNSTransaction in Own Shares
24th Apr 20249:41 amRNSTransaction in Own Shares
23rd Apr 20249:34 amRNSTransaction in Own Shares
22nd Apr 20249:43 amRNSTransaction in Own Shares
17th Apr 20249:23 amRNSTransaction in Own Shares
16th Apr 20249:44 amRNSTransaction in Own Shares
15th Apr 20249:12 amRNSTransaction in Own Shares
12th Apr 20249:43 amRNSTransaction in Own Shares
11th Apr 20249:35 amRNSTransaction in Own Shares
10th Apr 202411:34 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSYear end trading summary and date of results
9th Apr 20249:38 amRNSTransaction in Own Shares
5th Apr 20249:25 amRNSTransaction in Own Shares
4th Apr 20249:33 amRNSTransaction in Own Shares
3rd Apr 20249:22 amRNSTransaction in Own Shares
28th Mar 202411:41 amRNSTransaction in Own Shares
27th Mar 20249:57 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSGrant and variation of Options
26th Mar 202410:31 amRNSTransaction in Own Shares
25th Mar 202412:24 pmRNSTransaction in Own Shares
22nd Mar 20249:01 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSDirector/PDMR Dealings
21st Mar 20249:14 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSMercia secures two further BBB contracts
20th Mar 20249:32 amRNSTransaction in Own Shares
18th Mar 20249:59 amRNSTransaction in Own Shares
15th Mar 20249:04 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMercia completes three syndicated funding rounds
13th Mar 202411:24 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSMercia's Northern VCTs raise £60.0million
12th Mar 20249:46 amRNSTransaction in Own Shares
11th Mar 20249:16 amRNSTransaction in Own Shares
8th Mar 202410:14 amRNSTransaction in Own Shares
7th Mar 202410:15 amRNSTransaction in Own Shares
5th Mar 202410:16 amRNSTransaction in Own Shares
4th Mar 20249:44 amRNSTransaction in Own Shares
1st Mar 202410:11 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSNew British Business Bank contracts
28th Feb 20248:38 amRNSTransaction in Own Shares
27th Feb 20248:44 amRNSTransaction in Own Shares
26th Feb 20248:49 amRNSTransaction in Own Shares
23rd Feb 20249:25 amRNSTransaction in Own Shares
21st Feb 20249:29 amRNSTransaction in Own Shares
16th Feb 20248:59 amRNSTransaction in Own Shares
15th Feb 20249:31 amRNSTransaction in Own Shares
9th Feb 20249:46 amRNSTransaction in Own Shares
8th Feb 20249:41 amRNSTransaction in Own Shares
7th Feb 20249:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.